These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 23798363

  • 21. Rituximab before splenectomy in adults with primary idiopathic thrombocytopenic purpura: a meta-analysis.
    Auger S, Duny Y, Rossi JF, Quittet P.
    Br J Haematol; 2012 Aug; 158(3):386-98. PubMed ID: 22612239
    [Abstract] [Full Text] [Related]

  • 22. [Persistent hypogammaglobulinemia in an ITP patient following treatment with rituximab].
    Toubi E.
    Harefuah; 2012 Nov; 151(11):620-1, 655. PubMed ID: 23367731
    [Abstract] [Full Text] [Related]

  • 23. Rituximab-induced hepatitis C virus reactivation in rheumatoid arthritis.
    Lin KM, Lin JC, Tseng WY, Cheng TT.
    J Microbiol Immunol Infect; 2013 Feb; 46(1):65-7. PubMed ID: 22627098
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITP.
    Zhou H, Xu M, Qin P, Zhang HY, Yuan CL, Zhao HG, Cui ZG, Meng YS, Wang L, Zhou F, Wang X, Li DQ, Bi KH, Zhu CS, Guo CS, Chu XX, Wu QC, Liu XG, Dong XY, Li J, Peng J, Hou M.
    Blood; 2015 Mar 05; 125(10):1541-7. PubMed ID: 25575541
    [Abstract] [Full Text] [Related]

  • 26. Longterm effects of rituximab on B cell counts and autoantibody production in rheumatoid arthritis: use of high-sensitivity flow cytometry for more sensitive assessment of B cell depletion.
    Váncsa A, Szabó Z, Szamosi S, Bodnár N, Végh E, Gergely L, Szucs G, Szántó S, Szekanecz Z.
    J Rheumatol; 2013 May 05; 40(5):565-71. PubMed ID: 23547216
    [Abstract] [Full Text] [Related]

  • 27. Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura.
    Arnold DM, Dentali F, Crowther MA, Meyer RM, Cook RJ, Sigouin C, Fraser GA, Lim W, Kelton JG.
    Ann Intern Med; 2007 Jan 02; 146(1):25-33. PubMed ID: 17200219
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Hydroxychloroquine is a good second-line treatment for adults with immune thrombocytopenia and positive antinuclear antibodies.
    Khellaf M, Chabrol A, Mahevas M, Roudot-Thoraval F, Limal N, Languille L, Bierling P, Michel M, Godeau B.
    Am J Hematol; 2014 Feb 02; 89(2):194-8. PubMed ID: 24254965
    [Abstract] [Full Text] [Related]

  • 30. All-trans retinoic acid plus low-dose rituximab vs low-dose rituximab in corticosteroid-resistant or relapsed ITP.
    Wu YJ, Liu H, Zeng QZ, Liu Y, Wang JW, Wang WS, Jia-Feng, Zhou HB, Huang QS, He Y, Fu HX, Zhu XL, Jiang Q, Jiang H, Chang YJ, Xu LP, Huang XJ, Zhang XH.
    Blood; 2022 Jan 20; 139(3):333-342. PubMed ID: 34665865
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura.
    Cooper N, Stasi R, Cunningham-Rundles S, Feuerstein MA, Leonard JP, Amadori S, Bussel JB.
    Br J Haematol; 2004 Apr 20; 125(2):232-9. PubMed ID: 15059147
    [Abstract] [Full Text] [Related]

  • 33. Rituximab for management of refractory pregnancy-associated immune thrombocytopenic purpura.
    Gall B, Yee A, Berry B, Bircham D, Hayashi A, Dansereau J, Hart J.
    J Obstet Gynaecol Can; 2010 Dec 20; 32(12):1167-1171. PubMed ID: 21176329
    [Abstract] [Full Text] [Related]

  • 34. Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients.
    Khellaf M, Charles-Nelson A, Fain O, Terriou L, Viallard JF, Cheze S, Graveleau J, Slama B, Audia S, Ebbo M, Le Guenno G, Cliquennois M, Salles G, Bonmati C, Teillet F, Galicier L, Hot A, Lambotte O, Lefrère F, Sacko S, Kengue DK, Bierling P, Roudot-Thoraval F, Michel M, Godeau B.
    Blood; 2014 Nov 20; 124(22):3228-36. PubMed ID: 25293768
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Safety of rituximab in combination with other biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: an open-label study.
    Rigby WF, Mease PJ, Olech E, Ashby M, Tole S.
    J Rheumatol; 2013 May 20; 40(5):599-604. PubMed ID: 23547218
    [Abstract] [Full Text] [Related]

  • 37. Safety and effectiveness of rituximab in patients with rheumatoid arthritis following an inadequate response to 1 prior tumor necrosis factor inhibitor: the RESET Trial.
    Haraoui B, Bokarewa M, Kallmeyer I, Bykerk VP, RESET Investigators.
    J Rheumatol; 2011 Dec 20; 38(12):2548-56. PubMed ID: 21965646
    [Abstract] [Full Text] [Related]

  • 38. Adult primary and secondary immune thrombocytopenic purpura: a comparative analysis of characteristics and clinical course.
    Ayesh MH, Alawneh K, Khassawneh B, Khader Y, Kasasbeh A.
    Clin Appl Thromb Hemost; 2013 Jun 20; 19(3):327-30. PubMed ID: 22275396
    [Abstract] [Full Text] [Related]

  • 39. [Treatment of immune thrombocytopenia: a retrospective study of 40 patients].
    Audia S, Lakomy D, Guy J, Leguy-Seguin V, Berthier S, Aho S, Lorcerie B, Bonnotte B.
    Rev Med Interne; 2010 May 20; 31(5):337-44. PubMed ID: 20409619
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.